Germany's Federal Court of Justice - wingrim / Shutterstock.com
The Federal Court of Justice of Germany, the country’s highest court, has rejected an appeal from AstraZeneca (AZ) in which the pharmaceutical company claimed that a patent used in its drug Seroquel XR (quetiapine) is valid.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
AstraZeneca; Seroquel XR; patent infringement; Federal Court of Justice of Germany
